Patents by Inventor Phillip Barter

Phillip Barter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Screening method for an agent having an affect on a sphingosine kinase signaling pathway
    Publication number: 20050074830
    Abstract: The present invention relates generally to a method of modulating cellular activity and agents useful for same. More particularly, the present invention contemplates a method of modulating endothelial cell activity and even more particularly endothelial cell adhesion molecule expression. Most particularly, the present invention provides a method of treating coronary heart disease by preventing or reducing endothelial cell adhesion molecule expression.
    Type: Application
    Filed: October 7, 2003
    Publication date: April 7, 2005
    Inventors: Jennifer Gamble, Mathew Vadas, Pu Xia, Phillip Barter, Kerry-Anne Rye, Brian Wattenberg, Stuart Pitson
  • Spheroidal hdl particles with a defined phospholipid composition
    Publication number: 20040266662
    Abstract: Spheroidal reconstituted HDL particles with a defined phospholipid composition have been formed for the first time. The spheroidal HDL particle are formed from discoidal HDL particles of defined phospholid composition to which is added in multiple stepwise format unesterified cholesterol carried in a solvent, followed by addition of a LCAT. Lysophopholipids are removed and a specific sequence of addition of reagents are found to be beneficial. Additionally it is found that a ratio of phospholipids to apoprotein A-1 of about 100:1 enhances the result.
    Type: Application
    Filed: May 6, 2004
    Publication date: December 30, 2004
    Inventors: Kerry-Anne Rye, Phillip Barter
  • Screening method for an agent having an effect on a sphingosine kinase signaling pathway
    Patent number: 6649362
    Abstract: A screening method for identifying a therapeutic candidate for a coronary heart disease or an inflammatory condition is disclosed. The screening method tests for the presence or absence of an effect by a putative therapeutic agent on a component of a sphingosine kinase signaling pathway.
    Type: Grant
    Filed: October 16, 2001
    Date of Patent: November 18, 2003
    Assignee: Medvet Science Pty. Ltd.
    Inventors: Jennifer Gamble, Mathew Vadas, Pu Xia, Phillip Barter, Kerry-Anne Rye, Brian Wattenberg, Stuart Pitson
  • Method of modulating cellular activity
    Publication number: 20020051777
    Abstract: The present invention relates generally to a method of modulating cellular activity and agents useful for same. More particularly, the present invention contemplates a method of modulating endothelial cell activity and even more particularly endothelial cell adhesion molecule expression. Most particularly, the present invention provides a method of treating coronary heart disease by preventing or reducing endothelial cell adhesion molecule expression.
    Type: Application
    Filed: October 16, 2001
    Publication date: May 2, 2002
    Inventors: Jennifer Gamble, Mathew Vadas, Pu Xia, Phillip Barter, Kerry-Anne Rye, Brian Wattenberg, Stuart Pitson